reference/35047926

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35047926

Outgoing Links

Predicate	Object
contentType	Randomized Controlled Trial\|Multicenter Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	881
issn	2213-8587
issueIdentifier	12
pageRange	869-881
publicationName	The lancet. Diabetes & endocrinology
startingPage	869
bibliographicCitation	Inzucchi SE, Claggett BL, Vaduganathan M, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Verma S, Han Y, Kerr Saraiva JF, Bengtsson O, Petersson M, Langkilde AM, McMurray JJV, Solomon SD. Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2022 Dec;10(12):869–81. doi: 10.1016/s2213-8587(22)00308-4. PMID: 36372069.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff36fcc7c9abb4ddbe6087df805cfc2a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15c7fdc1f2b927ec14f84b83926cd30f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a383ce7b06fcea71f1c466ef69e5da49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e55698f12c96ad7bf1576a34c55b85f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d97ed57a6e7ee83493044c5ea05f4b83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d2c9275687507945873280e6d87bb0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74ddb8ca0168112b57784cb64c03e831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0754c2f4744a6720138783f7be73cd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1dbeea5c0fc762b3886c07c650daa3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff8d485a7887ae4186700e47a3a66ab8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44fc342451e5b69ff3210435d015c570 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb6b07ed3e7be293b7bfcfa58a0d8c38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65d9a2d35431a35d5088365c3eba99a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8782d47cbb33b0cfeb5f2352b43192b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fe50a78039960ea3bfcf77547da6763 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89ae7541f3ebef3d751ac988592f3e54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d6e3b6e3a1f00c54f6bcbb889c24e76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ce3a83f27325f10627fc685745794f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31c86f2c0e32eb0bea1006b14461447f
date	202212
identifier	https://doi.org/10.1016/s2213-8587%2822%2900308-4 https://pubmed.ncbi.nlm.nih.gov/36372069
isPartOf	https://portal.issn.org/resource/ISSN/2213-8587 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41837
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0522017
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011236Q000150 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D006333Q000188 http://id.nlm.nih.gov/mesh/D006333Q000150 http://id.nlm.nih.gov/mesh/D003924Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013318 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001786 http://id.nlm.nih.gov/mesh/D016277 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8959 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7922 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887712 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7920 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6863 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121

Showing number of triples: 1 to 58 of 58.